Presentation is loading. Please wait.

Presentation is loading. Please wait.

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer 

Similar presentations


Presentation on theme: "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer "— Presentation transcript:

1 Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer  Katsutoshi Enokido, Chie Watanabe, Seigo Nakamura, Akiko Ogiya, Tomo Osako, Futoshi Akiyama, Akiyo Yoshimura, Hiroji Iwata, Shinji Ohno, Yasuyuki Kojima, Koichiro Tsugawa, Kazuyoshi Motomura, Naoki Hayashi, Hideko Yamauchi, Nobuaki Sato  Clinical Breast Cancer  Volume 16, Issue 4, Pages (August 2016) DOI: /j.clbc Copyright © 2016 The Authors Terms and Conditions

2 Figure 1 Tumor Identification Rate According to Clinical Tumor Biomarkers Abbreviations: ER = estrogen receptor; HER2 = human epithelial growth factor 2; TNBC = triple-negative breast cancer. Clinical Breast Cancer  , DOI: ( /j.clbc ) Copyright © 2016 The Authors Terms and Conditions

3 Figure 2 False-Negative Rate According to Clinical Tumor Biomarkers
Abbreviations: ER = estrogen receptor; HER2 = human epithelial growth factor 2; TNBC = triple-negative breast cancer. Clinical Breast Cancer  , DOI: ( /j.clbc ) Copyright © 2016 The Authors Terms and Conditions


Download ppt "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer "

Similar presentations


Ads by Google